Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XWTYJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DXC-005
|
|||||
| Synonyms |
DXC 005; DXC-005; DXC005; DAC 005; DAC-005; DAC005; Recombinant humanized anti-Muc1 antibody conjugated to Tub201; Recombinant humanized anti-Muc1 antibody conjugated to Tub201(Hangzhou DAC Biotechnology)
Click to Show/Hide
|
|||||
| Organization |
Hangzhou DAC Biotech Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
4.0 to 4.2
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Mucin-1 (MUC1)
|
Antigen Info | ||||
| Payload Name |
Tubulysin B analog Tub201
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
